Exelixis, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved CABOMETYX® (cabozantinib) for the treatment of 1) adult and pediatric patients 12 years of age and older ...

RE/MAX the #1 name in real estate1, is honored to announce consumers have once again voted RE/MAX® as the brand with the #1 Most Trusted Real Estate Agents in the U.S.2 and Canada3. This esteemed ...

After hours: March 24 at 5:48:17 PM EDT Loading Chart for ETWO ...

1 Day ETWO 0.45% DJIA 0.08% Russell 2K -0.56% Technology 0.49% ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...